Opyl Limited (ASX:OPL) Insider Purchases A$262,003.35 in Stock

Opyl Limited (ASX:OPL) insider Antanas (Tony) Guoga purchased 3,059 shares of the firm’s stock in a transaction on Friday, March 28th. The stock was bought at an average cost of A$85.65 ($53.87) per share, with a total value of A$262,003.35 ($164,781.98).

Opyl Price Performance

The stock has a market cap of $3.28 million, a PE ratio of -0.93 and a beta of 1.89.

Opyl Company Profile

Opyl Limited develops digital tools that enhance healthcare experience for patients in Australia. The company also delivers deep market insights from social media data and enhance clinical research process. It offers Opin, a clinical trial recruitment platform that leverages social media, search engine optimization technologies and emerging artificial intelligence science, and matching patients directly to clinical trials.